News: Companies and Markets
Latest in Companies and Markets
Investment by the US biopharmaceutical industry into the research and development (R&D) of new medicines and vaccines reached $65.3bn in 2009, an increase of more than $1.5bn from 2008, according to a new report.
17 March 2010
Eli Lilly Snaps Up Underarm Testosterone Treatment
16 March 2010
16 March 2010
OSI Board Rejects $3.5bn Astellas Offer
16 March 2010
16 March 2010
IBS Market to Triple to $1.52bn by 2018
16 March 2010
16 March 2010
Sigma-Aldrich to Sell Pfizer's Bioactive Small Molecules
15 March 2010
15 March 2010
Ranbaxy and Takeda Settle Diabetes Drug Dispute
15 March 2010
15 March 2010
Chesapeake Develops Paperboard Packaging for Pharma Use
15 March 2010
15 March 2010
Daiichi Sankyo Sees Ranbaxy Freedom as Key to Growth
12 March 2010
12 March 2010
AstraZeneca Strikes Torrent Generic Deal
12 March 2010
12 March 2010
Watson's Long-Acting Prostate Cancer Agonist Approved
12 March 2010
12 March 2010
